These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 2919535

  • 1. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI, Reiffel JA, Bigger JT, Squatrito A, Kidwell GA.
    Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
    Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA.
    Am Heart J; 1995 Apr; 129(4):739-48. PubMed ID: 7900626
    [Abstract] [Full Text] [Related]

  • 4. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F, Iturralde Torres P, Picos Bovio E, Medeiros Domingo A, Infante Vázquez O.
    Arch Inst Cardiol Mex; 1998 Apr; 68(6):482-91. PubMed ID: 10365224
    [Abstract] [Full Text] [Related]

  • 5. Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter.
    Tai CT, Chen SA, Chiang CE, Lee SH, Ueng KC, Wen ZC, Huang JL, Chen YJ, Yu WC, Feng AN, Chiou CW, Chang MS.
    Circulation; 1997 Oct 21; 96(8):2601-11. PubMed ID: 9355900
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of diltiazem in supraventricular paroxysmal tachyarrhythmias].
    De Rosa F, Feraco E, Venneri N, Boncompagni F, Curia F, Guzzo D, Plastina F.
    G Ital Cardiol; 1986 Sep 21; 16(9):776-81. PubMed ID: 3803800
    [Abstract] [Full Text] [Related]

  • 8. Sotalol in patients with Wolff-Parkinson-White syndrome.
    Kunze KP, Schlüter M, Kuck KH.
    Circulation; 1987 May 21; 75(5):1050-7. PubMed ID: 3568305
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK, Venkatesh N, Singh BN.
    Circulation; 1986 Jul 21; 74(1):197-204. PubMed ID: 3708774
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.
    Alboni P, Razzolini R, Scarfò S, Paparella N, Fucà G, Pedini I, Chioin R.
    J Am Coll Cardiol; 1993 Nov 01; 22(5):1373-7. PubMed ID: 8227794
    [Abstract] [Full Text] [Related]

  • 11. Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.
    Daubert C, Mabo P, Gras D, Leclercq C.
    Eur Heart J; 1993 Nov 01; 14 Suppl H():67-73. PubMed ID: 7904939
    [Abstract] [Full Text] [Related]

  • 12. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G, Furlanello F, Vergara G, Guarnerio M, Braito G, Nassivera E.
    G Ital Cardiol; 1992 Jun 01; 22(6):701-13. PubMed ID: 1426808
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias.
    Vietti-Ramus G, Veglio F, Marchisio U, Burzio P, Latini R.
    Int J Cardiol; 1992 Apr 01; 35(1):77-85. PubMed ID: 1563883
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A, Tani M, Mizumaki K, Shimono M, Inoue H.
    J Cardiovasc Pharmacol; 1994 Mar 01; 23(3):374-8. PubMed ID: 7515979
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X, Zhang Y, Liu H, Jiang H, Ge H, Zhang Y.
    Am J Cardiol; 2017 May 01; 119(9):1366-1370. PubMed ID: 28283175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Intravenous sotalol in the acute treatment of supraventricular tachycardias].
    Lévy S, Rovini JC, Metge M, Cointe R, Bru P, Nassi C, Gérard R.
    Arch Mal Coeur Vaiss; 1986 Nov 01; 79(12):1781-5. PubMed ID: 3105490
    [Abstract] [Full Text] [Related]

  • 18. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study.
    Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R.
    Anesth Analg; 2008 Nov 01; 107(5):1514-22. PubMed ID: 18931208
    [Abstract] [Full Text] [Related]

  • 19. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA, Kuhn RJ, McCaffrey FM.
    Ann Pharmacother; 1997 Nov 25; 31(11):1347-59. PubMed ID: 9391691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.